Aprea Therapeutics Stock Market Value
| APRE Stock | USD 0.61 0.03 4.69% |
| Symbol | Aprea |
Will Biotechnology sector continue expanding? Could Aprea diversify its offerings? Factors like these will boost the valuation of Aprea Therapeutics. If investors know Aprea will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aprea Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.12) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Understanding Aprea Therapeutics requires distinguishing between market price and book value, where the latter reflects Aprea's accounting equity. The concept of intrinsic value - what Aprea Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Aprea Therapeutics' price substantially above or below its fundamental value.
Understanding that Aprea Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aprea Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aprea Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Aprea Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aprea Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aprea Therapeutics.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Aprea Therapeutics on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Aprea Therapeutics or generate 0.0% return on investment in Aprea Therapeutics over 90 days. Aprea Therapeutics is related to or competes with Acurx Pharmaceuticals, Biocardia, Kiora Pharmaceuticals, Galecto, Adial Pharmaceuticals, In8bio, and Creative Medical. Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel ca... More
Aprea Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aprea Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aprea Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 46.26 | |||
| Value At Risk | (10.58) | |||
| Potential Upside | 4.44 |
Aprea Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aprea Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aprea Therapeutics' standard deviation. In reality, there are many statistical measures that can use Aprea Therapeutics historical prices to predict the future Aprea Therapeutics' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.03) | |||
| Total Risk Alpha | (1.61) | |||
| Treynor Ratio | (0.36) |
Aprea Therapeutics February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.35) | |||
| Mean Deviation | 3.99 | |||
| Coefficient Of Variation | (831.81) | |||
| Standard Deviation | 6.72 | |||
| Variance | 45.15 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (1.03) | |||
| Total Risk Alpha | (1.61) | |||
| Treynor Ratio | (0.36) | |||
| Maximum Drawdown | 46.26 | |||
| Value At Risk | (10.58) | |||
| Potential Upside | 4.44 | |||
| Skewness | 1.87 | |||
| Kurtosis | 13.8 |
Aprea Therapeutics Backtested Returns
Aprea Therapeutics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Aprea Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aprea Therapeutics' Risk Adjusted Performance of (0.09), standard deviation of 6.72, and Mean Deviation of 3.99 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.25, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aprea Therapeutics will likely underperform. At this point, Aprea Therapeutics has a negative expected return of -0.91%. Please make sure to confirm Aprea Therapeutics' potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Aprea Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.74 |
Good predictability
Aprea Therapeutics has good predictability. Overlapping area represents the amount of predictability between Aprea Therapeutics time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aprea Therapeutics price movement. The serial correlation of 0.74 indicates that around 74.0% of current Aprea Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.73 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aprea Therapeutics is a strong investment it is important to analyze Aprea Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aprea Therapeutics' future performance. For an informed investment choice regarding Aprea Stock, refer to the following important reports:Check out Aprea Therapeutics Correlation, Aprea Therapeutics Volatility and Aprea Therapeutics Performance module to complement your research on Aprea Therapeutics. For information on how to trade Aprea Stock refer to our How to Trade Aprea Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Aprea Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.